A WDR35-dependent coat protein complex transports ciliary membrane cargo vesicles to cilia
- MRC Institute of Genetics and Molecular Medicine, United Kingdom
- Aarhus University, Denmark
- MRC Human Genetics Unit, University of Edinburgh, United Kingdom
- Max-Planck Institute of Molecular Cell Biology and Genetics, Germany
- Max Planck Institute of Molecular Cell Biology and Genetics, Germany
- The University of Edinburgh, United Kingdom
- University of Edinburgh, United Kingdom
- Human Technopole, Italy
Abstract
Intraflagellar transport (IFT) is a highly conserved mechanism for motor-driven transport of cargo within cilia, but how this cargo is selectively transported to cilia is unclear. WDR35/IFT121 is a component of the IFT-A complex best known for its role in ciliary retrograde transport. In the absence of WDR35, small mutant cilia form but fail to enrich in diverse classes of ciliary membrane proteins. In Wdr35 mouse mutants, the non-core IFT-A components are degraded and core components accumulate at the ciliary base. We reveal deep sequence homology of WDR35 and other IFT-A subunits to α and ß' COPI coatomer subunits, and demonstrate an accumulation of 'coat-less' vesicles which fail to fuse with Wdr35 mutant cilia. We determine that recombinant non-core IFT-As can bind directly to lipids and provide the first in-situ evidence of a novel coat function for WDR35, likely with other IFT-A proteins, in delivering ciliary membrane cargo necessary for cilia elongation.
Data availability
Source Data (Figures 1B,C; 2B; 3B; as well as Figure 3 Supplement 1C, Figure 7 Supplement-1C) have been uploaded with the submission containing numerical data of all graphs shown in the figures and figure supplements. We have also uploaded the Excel or/and Prism files as source data in addition to the data points which have been referenced, as appropriate in the Figure legends. Source data of raw and full uncropped blots for Figures 3B, C, E and Figure 3 Supplement 1A, as well as Figure 5B, C and Figure 5 Supplement 1 B-D are uploaded as zipped files per figure. For Figure 7F, we have included the ROIs used for calculations uploaded in a single folder including all numerical data of Figure 7 (7B-D,F) graphs at Dryad https://doi.org/10.5061/dryad.m37pvmd33. All analysis tools have been made available on GitHub (https://github.com/IGMM-ImagingFacility/Quidwai2020 WDR35paper), as described in Materials and Methods. Proteomics data files are be uploaded ProteomeXchange (Identifer: PXD022652), with the accession number is available with the paper and is now publically available.Project Name: A WDR35-dependent coatomer transports ciliary membrane proteins from the Golgi to the ciliaProject accession: PXD022652
-
Figure 7- source data 1.Dryad Digital Repository, doi:10.5061/dryad.m37pvmd33.
Article and author information
Author details
Funding
European Molecular Biology Laboratory (Short Term Fellowship)
- Tooba Quidwai
European Commission (H2020,Grant Agreement number 888322)
- Narcis A Petriman
Lister Institute of Preventive Medicine (Research Prize Fellow)
- Joseph A Marsh
Novo Nordisk (Grant No. NNF15OC0014164)
- Jiaolong Wang
- Narcis A Petriman
- Esben Lorentzen
Carlsbergfondet (Grant No. CF19-0253)
- Jiaolong Wang
- Narcis A Petriman
- Esben Lorentzen
European Commission (H2020 Grant No. 819826)
- Weihua Leng
- Petra Kiesel
- Gaia Pigino
European Commission (H2020 No. 866355)
- Tooba Quidwai
- Emma A Hall
- Pleasantine Mill
Medical Research Council (Core unit funding No. MC_UU_12018/26)
- Tooba Quidwai
- Emma A Hall
- Laura C Murphy
- Margaret A Keighren
- Pleasantine Mill
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: We followed international, national and institutional guidelines for the care and use of animals. Animal experiments were carried out under UK Home Office Project Licenses PPL 60/4424, PB0DC8431 and P18921CDE in facilities at the University of Edinburgh (PEL 60/2605) and were approved by the University of Edinburgh animal welfare and ethical review body.
Copyright
© 2021, Quidwai et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,744
- views
-
- 555
- downloads
-
- 38
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
A WDR35-dependent coat protein complex transports ciliary membrane cargo vesicles to cilia
eLife 10:e69786.
https://doi.org/10.7554/eLife.69786
Further reading
-
- Cell Biology
Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.
-
- Cell Biology
- Developmental Biology
A study in mice reveals key interactions between proteins involved in fibroblast growth factor signaling and how they contribute to distinct stages of eye lens development.
